\-\ Texto\\:\\ \ \(0\)\
\-\ normal\\ mammogram\\ one\\ year\\ prior\\.\ \(0\)\
\-\ annual\\ mammogram\\.\\ \\ monthly\\ self\\-breast\\ exams\\.\ \(0\)\
\-\ spontaneous\\ appearance\\ of\\ pleomorphic\\ calcifications\\ within\\ the\\ left\\ nipple\\.\\ \\ no\\ calcifications\\ were\\ present\\ one\\ year\\ prior\\.\\ no\\ calcifications\\ present\\ within\\ right\\ breast\\.\ \(0\)\
\-\ benign\\ calcifications\ \(5\)\
\-\ \\â\\€\\¢\\ benign\\ calcifications\\ \\(secretory\\)\ \(0\)\
\-\ \\â\\€\\¢\\ intraductal\\ papilloma\ \(0\)\
\-\ \\â\\€\\¢\\ paget\\'s\\ disease\\ of\\ nipple\ \(0\)\
\-\ \\â\\€\\¢\\ malignant\\/suspicious\\ \\-\\ bx\\ required\ \(0\)\
\-\ 61\\ y\\.o\\.\\ woman\\,\\ clinically\\ asymptomatic\\ for\\ routine\\ screening\\ mammogram\\.\ \(1\)\
\-\ pleomorphic\\ calcification\\ should\\ be\\ biopsied\\.\\ \\ in\\ this\\ case\\,\\ they\\ were\\ benign\\.\\ \\ the\\ unique\\ aspect\\ of\\ this\\ case\\ was\\ that\\ unilateral\\ nipple\\ calcification\\ appeared\\ within\\ the\\ course\\ of\\ one\\ year\\.\\ \\ no\\ nipple\\ calcifications\\ were\\ present\\ on\\ any\\ prior\\ mammograms\\.\\ if\\ bilateral\\ calcifications\\ were\\ present\\,\\ the\\ more\\ likely\\ possibility\\ would\\ have\\ been\\ calcified\\ secretory\\ deposits\\,\\ perhaps\\ from\\ sebaceous\\ glands\\ of\\ the\\ nipple\\.\ \(0\)\
\-\ from\\ the\\ mammographic\\ appearance\\,\\ an\\ intraductal\\ papilloma\\ had\\ to\\ be\\ excluded\\.\\ \\ however\\,\\ from\\ a\\ clinical\\ standpoint\\,\\ the\\ patient\\ had\\ no\\ evidence\\ of\\ nipple\\ discharge\\,\\ which\\ is\\ typically\\ the\\ first\\ symptom\\ of\\ intraductal\\ papilloma\\.\ \(0\)\
\-\ after\\ excision\\,\\ the\\ pathology\\ simply\\ stated\\ benign\\ calcifications\\ within\\ normal\\ nipple\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ nipple\\:\\ 0\\.5026796808866358\ \(0\)\
\-\ calcifications\\:\\ 0\\.3965377433127337\ \(0\)\
\-\ intraductal\\:\\ 0\\.2370842931624221\ \(0\)\
\-\ mammogram\\:\\ 0\\.1945297167142465\ \(0\)\
\-\ secretory\\:\\ 0\\.18739625227545334\ \(0\)\
\-\ papilloma\\:\\ 0\\.18683172072040338\ \(0\)\
\-\ benign\\:\\ 0\\.18661686070731545\ \(0\)\
\-\ were\\:\\ 0\\.14003646430083985\ \(0\)\
\-\ present\\:\\ 0\\.1394011369651075\ \(0\)\
\-\ pleomorphic\\:\\ 0\\.13745869990411644\ \(0\)\
\-\ within\\:\\ 0\\.12512142121472106\ \(0\)\
\-\ the\\:\\ 0\\.12196665189589749\ \(0\)\
\-\ one\\:\\ 0\\.11665656239029314\ \(0\)\
\-\ prior\\:\\ 0\\.11399860301154692\ \(0\)\
\-\ breast\\:\\ 0\\.09863833029837278\ \(0\)\
\-\ calcification\\:\\ 0\\.09697909780565635\ \(0\)\
\-\ standpoint\\:\\ 0\\.09553345986372598\ \(0\)\
\-\ of\\:\\ 0\\.09303703535820475\ \(0\)\
\-\ no\\:\\ 0\\.08834300182127958\ \(0\)\
\-\ bx\\:\\ 0\\.08831674512672373\ \(0\)\
\-\ monthly\\:\\ 0\\.08728077879226667\ \(0\)\
\-\ mammographic\\:\\ 0\\.08462400889721879\ \(0\)\
\-\ sebaceous\\:\\ 0\\.08385560667802236\ \(0\)\
\-\ simply\\:\\ 0\\.08313380374357963\ \(0\)\
\-\ appearance\\:\\ 0\\.08188873828000173\ \(0\)\
\-\ from\\:\\ 0\\.08092094712253213\ \(0\)\
\-\ biopsied\\:\\ 0\\.08006406405526442\ \(0\)\
\-\ perhaps\\:\\ 0\\.07807510107442107\ \(0\)\
\-\ deposits\\:\\ 0\\.07719276399480807\ \(0\)\
\-\ unique\\:\\ 0\\.07637132782575948\ \(0\)\
\-\ mammograms\\:\\ 0\\.07598092884883628\ \(0\)\
\-\ glands\\:\\ 0\\.0720850985340028\ \(0\)\
\-\ symptom\\:\\ 0\\.06915461308875723\ \(0\)\
\-\ exams\\:\\ 0\\.06894008292334876\ \(0\)\
\-\ 61\\:\\ 0\\.06894008292334876\ \(0\)\
\-\ case\\:\\ 0\\.06824126147446744\ \(0\)\
\-\ had\\:\\ 0\\.06767723216542812\ \(0\)\
\-\ paget\\:\\ 0\\.06735024453510374\ \(0\)\
\-\ appeared\\:\\ 0\\.06716565010791388\ \(0\)\
\-\ stated\\:\\ 0\\.06716565010791388\ \(0\)\
\-\ excluded\\:\\ 0\\.06680483152398481\ \(0\)\
\-\ possibility\\:\\ 0\\.06315957731974747\ \(0\)\
\-\ year\\:\\ 0\\.06279180463708697\ \(0\)\
\-\ annual\\:\\ 0\\.06277339961642135\ \(0\)\
\-\ unilateral\\:\\ 0\\.06215636506937514\ \(0\)\
\-\ discharge\\:\\ 0\\.06090193201729792\ \(0\)\
\-\ spontaneous\\:\\ 0\\.05909756346364445\ \(0\)\
\-\ clinically\\:\\ 0\\.05644079356859655\ \(0\)\
\-\ normal\\:\\ 0\\.05545989761012115\ \(0\)\
\-\ screening\\:\\ 0\\.05517148718284765\ \(0\)\
\-\ be\\:\\ 0\\.05510221104549904\ \(0\)\
\-\ calcified\\:\\ 0\\.05471224174271707\ \(0\)\
\-\ excision\\:\\ 0\\.05354825157198673\ \(0\)\
\-\ pathology\\:\\ 0\\.05331705786004315\ \(0\)\
\-\ routine\\:\\ 0\\.05259525492560043\ \(0\)\
\-\ course\\:\\ 0\\.0501669325535655\ \(0\)\
\-\ they\\:\\ 0\\.04852777077210926\ \(0\)\
\-\ required\\:\\ 0\\.048489548902828174\ \(0\)\
\-\ would\\:\\ 0\\.048077012760452564\ \(0\)\
\-\ typically\\:\\ 0\\.04767829324064684\ \(0\)\
\-\ this\\:\\ 0\\.0466748286488868\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.046236414341882026\ \(0\)\
\-\ first\\:\\ 0\\.04583277900778029\ \(0\)\
\-\ should\\:\\ 0\\.04431566739736607\ \(0\)\
\-\ any\\:\\ 0\\.043893233657556756\ \(0\)\
\-\ aspect\\:\\ 0\\.04381566920045723\ \(0\)\
\-\ clinical\\:\\ 0\\.04304243593958128\ \(0\)\
\-\ likely\\:\\ 0\\.04058536399024725\ \(0\)\
\-\ however\\:\\ 0\\.04019876827227856\ \(0\)\
\-\ been\\:\\ 0\\.03956906091716433\ \(0\)\
\-\ if\\:\\ 0\\.039461312651875684\ \(0\)\
\-\ evidence\\:\\ 0\\.03854964232971549\ \(0\)\
\-\ more\\:\\ 0\\.037293553467600715\ \(0\)\
\-\ bilateral\\:\\ 0\\.03650096130076518\ \(0\)\
\-\ woman\\:\\ 0\\.035371259315063575\ \(0\)\
\-\ have\\:\\ 0\\.03392813606877617\ \(0\)\
\-\ after\\:\\ 0\\.03294752305267372\ \(0\)\
\-\ which\\:\\ 0\\.030882416597507564\ \(0\)\
\-\ that\\:\\ 0\\.029473317393659677\ \(0\)\
\-\ disease\\:\\ 0\\.028509033933951586\ \(0\)\
\-\ an\\:\\ 0\\.025971132707826205\ \(0\)\
\-\ was\\:\\ 0\\.023669655668550095\ \(0\)\
\-\ left\\:\\ 0\\.023167880662987448\ \(0\)\
\-\ right\\:\\ 0\\.02251720882386\ \(0\)\
\-\ patient\\:\\ 0\\.022089905437758094\ \(0\)\
\-\ for\\:\\ 0\\.020585042107991273\ \(0\)\
\-\ on\\:\\ 0\\.020512020707338204\ \(0\)\
\-\ is\\:\\ 0\\.018599460181781005\ \(0\)\
\-\ to\\:\\ 0\\.016979051140113815\ \(0\)\
\-\ in\\:\\ 0\\.016895480285566998\ \(0\)\
